Back to company

BioMed Invest ApS: Financial statements 2025

CVR: 29844925

BioMed Invest ApS (CVR 29844925) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 12,474 and a net result of DKK -80,320 compared with DKK 451,303 the year before. That is a decrease of 41.6% compared with the year before. Equity amounted to DKK 8,740,167. The solvency ratio was 99.2%. The company had 2 employees in the financial year.

Gross Profit
12,474 kr.
Profit/Loss
-80,320 kr.
Equity
8,740,167 kr.
Total Assets
8,808,583 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-12 t.-80 t.8.7 mio.2
2024-21 t.451 t.8.8 mio.2
2023-23 t.617 t.8.4 mio.2
2022-21 t.-878 t.7.8 mio.2
2021-2467.3 mio.8.6 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like BioMed Invest ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

BioMed Invest ApS: The 2024 annual report is outJun 27, 2025

BioMed Invest ApS has published its annual report for 2024. Gross profit came to DKK 21,365, and the net result was DKK 451,303.

About BioMed Invest ApS

BioMed Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2006. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Erling Henningsen. The company is owned by Erling Henningsen. In 2025, the company reported a gross profit of DKK 12,474 and a net result of DKK -80,320 compared with DKK 451,303 the year before. Equity amounted to DKK 8,740,167.